Referral criteria for chronic kidney disease: implications for disease management and healthcare expenditure-analysis of a population-based sample

被引:4
作者
Kiel, Simone [1 ]
Weckmann, Gesine [2 ]
Chenot, Jean-Francois [1 ]
Stracke, Sylvia [3 ,4 ]
Spallek, Jacob [5 ]
Angelow, Aniela [1 ]
机构
[1] Univ Med Greifswald, Inst Community Med, Dept Gen Practice, Fleischmannstr 6, D-17475 Greifswald, Germany
[2] European Univ Appl Sci, Fac Appl Hlth Sci, Rostock, Germany
[3] Univ Med Greifswald, Dept Internal Med A, Nephrol, Greifswald, Germany
[4] KfH Kidney Ctr Greifswald, Greifswald, Germany
[5] Brandenburg Univ Technol Cottbus Senftenberg, Dept Publ Hlth, Senftenberg, Germany
关键词
Chronic kidney disease; Referral; Guideline recommendations; Nephrology referral; Health care costs; RISK; FAILURE;
D O I
10.1186/s12882-022-02845-0
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background Clinical practice guidelines recommend specialist referral according to different criteria. The aim was to assess recommended and observed referral rate and health care expenditure according to recommendations from: center dot Kidney Disease Improving Global Outcomes (KDIGO,2012) center dot National Institute for Health and Care Excellence (NICE,2014) center dot German Society of Nephrology/German Society of Internal Medicine (DGfN/DGIM,2015) center dot German College of General Practitioners and Family Physicians (DEGAM,2019) center dot Kidney failure risk equation (NICE,2021) Methods Data of the population-based cohort Study of Health in Pomerania were matched with claims data. Proportion of subjects meeting referral criteria and corresponding health care expenditures were calculated and projected to the population of Mecklenburg-Vorpommern. Results Data from 1927 subjects were analysed. Overall proportion of subjects meeting referral criteria ranged from 4.9% (DEGAM) to 8.3% (DGfN/DGIM). The majority of patients eligible for referral were >= 60 years. In subjects older than 60 years, differences were even more pronounced, and rates ranged from 9.7% (DEGAM) to 16.5% (DGfN/DGIM). Estimated population level costs varied between euro1,432,440 (DEGAM) and euro2,386,186 (DGfN/DGIM). From 190 patients with eGFR < 60 ml/min, 15 had a risk of end stage renal disease > 5% within the next 5 years. Conclusions Applying different referral criteria results in different referral rates and costs. Referral rates exceed actually observed consultation rates. Criteria need to be evaluated in terms of available workforce, resources and regarding over- and underutilization of nephrology services.
引用
收藏
页数:11
相关论文
共 37 条
[1]  
[Anonymous], 2018, BEVOLKERUNGSSTAND BE
[2]   Causes and risk factors for acute dialysis initiation among patients with end-stage kidney disease-a large retrospective observational cohort study [J].
Arulkumaran, Nish ;
Navaratnarajah, Arunraj ;
Pillay, Camilla ;
Brown, Wendy ;
Duncan, Neill ;
McLean, Adam ;
Taube, David ;
Brown, Edwina A. .
CLINICAL KIDNEY JOURNAL, 2019, 12 (04) :550-558
[3]   Impact of Using Risk-Based Stratification on Referral of Patients With Chronic Kidney Disease From Primary Care to Specialist Care in the United Kingdom [J].
Bhachu, Harjeet K. ;
Cockwell, Paul ;
Subramanian, Anuradhaa ;
Adderley, Nicola J. ;
Gokhale, Krishna ;
Fenton, Anthony ;
Kyte, Derek ;
Nirantharakumar, Krishnarajah ;
Calvert, Melanie .
KIDNEY INTERNATIONAL REPORTS, 2021, 6 (08) :2189-2199
[4]   Early referral strategies for management of people with markers of renal disease: a systematic review of the evidence of clinical effectiveness, cost-effectiveness and economic analysis [J].
Black, C. ;
Sharma, P. ;
Scotland, G. ;
McCullough, K. ;
McGurn, D. ;
Robertson, L. ;
Fluck, N. ;
MacLeod, A. ;
McNamee, P. ;
Prescott, G. ;
Smith, C. .
HEALTH TECHNOLOGY ASSESSMENT, 2010, 14 (21) :1-+
[5]  
Blumel Miriam, 2020, Health Syst Transit, V22, P1
[6]   CKD Prevalence Varies across the European General Population [J].
Bruck, Katharina ;
Stel, Vianda S. ;
Gambaro, Giovanni ;
HaIlan, Stein ;
Volzke, Henry ;
Arnlov, Johan ;
Kastarinen, Mika ;
Guessous, Idris ;
Vinhas, Jose ;
Stengel, Benedicte ;
Brenner, Hermann ;
Chudek, Jerzy ;
Romundstad, Solfrid ;
Tomson, Charles ;
Otero Gonzalez, Alfonso ;
Bello, Aminu K. ;
Ferrieres, Jean ;
Palmieri, Luigi ;
Browne, Gemma ;
Capuano, Vincenzo ;
Van Biesen, Wim ;
Zoccali, Carmine ;
Gansevoort, Ron ;
Navis, Gerjan ;
Rothenbacher, Dietrich ;
Ferraro, Pietro Manuel ;
Nitsch, Dorothea ;
Wanner, Christoph ;
Jager, Kitty J. ;
Consortium, European C. K. D. Burden .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2016, 27 (07) :2135-2147
[7]   The global burden of chronic kidney disease [J].
Cockwell, Paul ;
Fisher, Lori-Ann .
LANCET, 2020, 395 (10225) :662-664
[8]   A longitudinal assessment of the natural rate of decline in renal function with age [J].
Cohen, Eytan ;
Nardi, Yuval ;
Krause, Irit ;
Goldberg, Elad ;
Milo, Gai ;
Garty, Moshe ;
Krause, Ilan .
JOURNAL OF NEPHROLOGY, 2014, 27 (06) :635-641
[9]   CKD: A Call for an Age-Adapted Definition [J].
Delanaye, Pierre ;
Jager, Kitty J. ;
Bokenkamp, Arend ;
Christensson, Anders ;
Dubourg, Laurence ;
Eriksen, Bjorn Odvar ;
Gaillard, Francois ;
Gambaro, Giovanni ;
van der Giet, Markus ;
Glassock, Richard J. ;
Indridason, Olafur S. ;
van Londen, Marco ;
Mariat, Christophe ;
Melsom, Toralf ;
Moranne, Olivier ;
Nordin, Gunnar ;
Palsson, Runolfur ;
Pottel, Hans ;
Rule, Andrew D. ;
Schaeffner, Elke ;
Taal, Maarten W. ;
White, Christine ;
Grubb, Anders ;
van den Brand, Jan A. J. G. .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2019, 30 (10) :1785-1805
[10]   Costs of patients with chronic kidney disease in Germany [J].
Gandjour, Afschin ;
Armsen, Wencke ;
Wehmeyer, Wolfgang ;
Multmeier, Jan ;
Tschulena, Ulrich .
PLOS ONE, 2020, 15 (04)